MDPI and ACS Style
Mendoza-Torreblanca, J.G.; Cárdenas-Rodríguez, N.; Carro-Rodríguez, J.; Contreras-García, I.J.; Garciadiego-Cázares, D.; Ortega-Cuellar, D.; Martínez-López, V.; Alfaro-Rodríguez, A.; Evia-Ramírez, A.N.; Ignacio-Mejía, I.;
et al. Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis. Int. J. Mol. Sci. 2023, 24, 10199.
https://doi.org/10.3390/ijms241210199
AMA Style
Mendoza-Torreblanca JG, Cárdenas-Rodríguez N, Carro-Rodríguez J, Contreras-García IJ, Garciadiego-Cázares D, Ortega-Cuellar D, Martínez-López V, Alfaro-Rodríguez A, Evia-Ramírez AN, Ignacio-Mejía I,
et al. Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis. International Journal of Molecular Sciences. 2023; 24(12):10199.
https://doi.org/10.3390/ijms241210199
Chicago/Turabian Style
Mendoza-Torreblanca, Julieta Griselda, Noemi Cárdenas-Rodríguez, Jazmín Carro-Rodríguez, Itzel Jatziri Contreras-García, David Garciadiego-Cázares, Daniel Ortega-Cuellar, Valentín Martínez-López, Alfonso Alfaro-Rodríguez, Alberto Nayib Evia-Ramírez, Iván Ignacio-Mejía,
and et al. 2023. "Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis" International Journal of Molecular Sciences 24, no. 12: 10199.
https://doi.org/10.3390/ijms241210199